Products
Fluphenazine was approved in many countries in 1971 and was commercially available as a solution for injection (Dapotum D), among other products. It has since been withdrawn from the market.
Structure and properties
Fluphenazine (C22H26F3N3OS, Mr = 437.5 g/mol)
Effects
Fluphenazine (ATC N05AB02) has antipsychotic properties.
Indications
Psychiatric disorders